PATH Malaria Vaccine Initiative
Novartis reports primary endpoint reached in phase 3 malaria trial
The treatment demonstrated non-inferiority to current standard of care
A Call to Action: Bridging the Adult Immunization Divide
Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...
Sanofi and Kling Bio partner to accelerate discovery of neutralising antibodies
The alliance will centre on Kling’s B cell immortalisation and screening platform Kling-Select
Prostate cancer blood test with ‘unprecedented accuracy’ cuts biopsies by 50%
There is currently no national screening programme for prostate cancer in the UK
Positive efficacy results for R21/Matrix-M malaria vaccine published in The Lancet
R21 was added to the World Health Organization's list of prequalified vaccines in December
World Health Organization adds second malaria vaccine to prequalification list
The addition is expected to result in sufficient malaria vaccine supply for children
WHO recommends second malaria vaccine for children
The addition of R21/Matrix-M to the organisation’s list is expected to result in sufficient malaria vaccine supply
GSK discovers strain of bacterium that stops malaria transmission
It is hoped that the discovery could contribute to the eradication of the disease
Video: Strategic engagement case study
Supporting the launch of a global vaccine with a programme of market research and strategic insights
Novartis and MMV to advance new malaria drug combination to phase 3 study
The announcement comes as the threat of resistance to current malaria treatments grows
WHO launches R&D efforts to identify pathogens that could cause future pandemics
Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’